The available data on the use of angiotensin-converting enzyme inhibitors, and the associated risks for contrast-induced nephropathy are sparse and conflicting. Nevertheless, it is a common practice to hold angiotensin-converting enzyme inhibitors before contrast media administration. The reduction of renal blood flow that occurs following the administration of contrast media may be due to the renin-angiotensin-aldosterone system causing constriction of the afferent arterioles. The influence of angiotensin-converting enzyme inhibitor administration on the development of contrast-induced nephropathy was discussed in this letter.

Download full-text PDF

Source
http://dx.doi.org/10.1080/08860220500461336DOI Listing

Publication Analysis

Top Keywords

enzyme inhibitors
12
contrast-induced nephropathy
12
angiotensin-converting enzyme
12
contrast media
8
angiotensin converting
4
enzyme
4
converting enzyme
4
inhibitors contrast-induced
4
nephropathy data
4
data angiotensin-converting
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!